|
Originally published In Press as doi:10.1194/jlr.M300250-JLR200 on September 16, 2003
Journal of Lipid Research, Vol. 45, 139-147, January 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Periodontitis decreases the antiatherogenic potency of high density lipoprotein
Pirkko J. Pussinen1,*,
Matti Jauhiainen ,
Tiina Vilkuna-Rautiainen*,
Jouko Sundvall ,
Marja Vesanen*,
Kimmo Mattila*,
Timo Palosuo ,
Georg Alfthan and
Sirkka Asikainen**
* Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
Department of Health and Functional Ability, National Public Health Institute, Helsinki, Finland
** Adhesion Center/Oral Microbiology, Department of Medicine and Odontology, Umeå University, Umeå, Sweden
1 To whom correspondence should be addressed. e-mail: pirkko.pussinen{at}helsinki.fi
Periodontitis, a consequence of persistent bacterial infection and chronic inflammation, has been suggested to predict coronary heart disease (CHD). The aim of this study was to investigate the impact of periodontitis on HDL structure and antiatherogenic function in cholesterol efflux in vitro. HDL was isolated from 30 patients (age 43.6 ± 6.1 years, mean ± SD) with periodontitis before and after (3.2 ± 1.4 months) periodontal treatment. The capacity of HDL for cholesterol efflux from macrophages (RAW 264.7), HDL composition, and key proteins of HDL metabolism were determined. After periodontal treatment, phospholipid transfer protein (PLTP) activity was 6.2% (P < 0.05) lower, and serum HDL cholesterol concentration, PLTP mass, and cholesteryl ester transfer protein activity were 10.7% (P < 0.001), 7.1% (P = 0.078), and 19.4% (P < 0.001) higher, respectively. The mean HDL2/HDL3 ratio increased from 2.16 ± 0.87 to 3.56 ± 0.48 (P < 0.05). HDL total phospholipid mass and sphingomyelin-phosphatidylcholine ratio were 7.4% (P < 0.05) and 36.8% (P < 0.001) higher, respectively. The HDL-mediated cholesterol efflux tended to be higher after periodontal treatment; interestingly, this increase was significant (P < 0.05) among patients whose C-reactive protein decreased (53.7% reduction, P = 0.015) and who were positive by PCR for Actinobacillus actinomycetemcomitans.
These results suggest that periodontitis causes similar, but milder, changes in HDL metabolism than those that occur during the acute-phase response and that periodontitis may diminish the antiatherogenic potency of HDL, thus increasing the risk for CHD.
Abbreviations: apoA-I, apolipoprotein A-I; CETP, cholesteryl ester transfer protein; CHD, coronary heart disease; CRP, C-reactive protein; HL, hepatic lipase; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PLTP, phospholipid transfer protein; PS, phosphatidylserine; SAA, serum amyloid A; SM, sphingomyelin; TG, triglyceride Supplementary key words HDL metabolism atherosclerosis reverse cholesterol transport cholesterol efflux inflammation

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Annema, N. Nijstad, M. Tolle, J. F. de Boer, R. V. C. Buijs, P. Heeringa, M. van der Giet, and U. J. F. Tietge
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
J. Lipid Res.,
April 1, 2010;
51(4):
743 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Feingold and C. Grunfeld
The acute phase response inhibits reverse cholesterol transport
J. Lipid Res.,
April 1, 2010;
51(4):
682 - 684.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kuula, T. Salo, E. Pirila, A. M. Tuomainen, M. Jauhiainen, V.-J. Uitto, L. Tjaderhane, P. J. Pussinen, and T. Sorsa
Local and Systemic Responses in Matrix Metalloproteinase 8-Deficient Mice during Porphyromonas gingivalis-Induced Periodontitis
Infect. Immun.,
February 1, 2009;
77(2):
850 - 859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. El Harchaoui, B. J. Arsenault, R. Franssen, J.-P. Despres, G. K. Hovingh, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, J. J.P. Kastelein, K.-T. Khaw, et al.
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Ann Intern Med,
January 20, 2009;
150(2):
84 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Vilkuna-Rautiainen, P. J Pussinen, M. Roivainen, T. Petays, P. Jousilahti, T. Hovi, E. Vartiainen, and S. Asikainen
Serum antibody response to periodontal pathogens and herpes simplex virus in relation to classic risk factors of cardiovascular disease
Int. J. Epidemiol.,
December 1, 2006;
35(6):
1486 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev.,
September 1, 2006;
58(3):
342 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paul-Satyaseela, M. Karched, Z. Bian, R. Ihalin, T. Boren, A. Arnqvist, C. Chen, and S. Asikainen
Immunoproteomics of Actinobacillus actinomycetemcomitans outer-membrane proteins reveal a highly immunoreactive peptidoglycan-associated lipoprotein.
J. Med. Microbiol.,
July 1, 2006;
55(Pt 7):
931 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Spahr, E. Klein, N. Khuseyinova, C. Boeckh, R. Muche, M. Kunze, D. Rothenbacher, G. Pezeshki, A. Hoffmeister, and W. Koenig
Periodontal Infections and Coronary Heart Disease: Role of Periodontal Bacteria and Importance of Total Pathogen Burden in the Coronary Event and Periodontal Disease (CORODONT) Study.
Arch Intern Med,
March 13, 2006;
166(5):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lakio, M. Lehto, A. M. Tuomainen, M. Jauhiainen, E. Malle, S. Asikainen, and P. J. Pussinen
Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans
Innate Immunity,
February 1, 2006;
12(1):
57 - 64.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Rufail, H. A. Schenkein, S. E. Barbour, J. G. Tew, and R. van Antwerpen
Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
J. Lipid Res.,
December 1, 2005;
46(12):
2752 - 2760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Pussinen, K. Nyyssonen, G. Alfthan, R. Salonen, J. A. Laukkanen, and J. T. Salonen
Serum Antibody Levels to Actinobacillus actinomycetemcomitans Predict the Risk for Coronary Heart Disease
Arterioscler Thromb Vasc Biol,
April 1, 2005;
25(4):
833 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D'Aiuto, L. Nibali, M. Parkar, J. Suvan, and M.S. Tonetti
Short-term Effects of Intensive Periodontal Therapy on Serum Inflammatory Markers and Cholesterol
Journal of Dental Research,
March 1, 2005;
84(3):
269 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Pussinen, T. Vilkuna-Rautiainen, G. Alfthan, T. Palosuo, M. Jauhiainen, J. Sundvall, M. Vesanen, K. Mattila, and S. Asikainen
Severe Periodontitis Enhances Macrophage Activation via Increased Serum Lipopolysaccharide
Arterioscler Thromb Vasc Biol,
November 1, 2004;
24(11):
2174 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Pussinen, G. Alfthan, H. Rissanen, A. Reunanen, S. Asikainen, and P. Knekt
Antibodies to Periodontal Pathogens and Stroke Risk
Stroke,
September 1, 2004;
35(9):
2020 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
J. Lipid Res.,
July 1, 2004;
45(7):
1169 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Navab, G. M. Ananthramaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, G. C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, et al.
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
J. Lipid Res.,
June 1, 2004;
45(6):
993 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Taguchi, M. Sanada, Y. Suei, M. Ohtsuka, K. Lee, K. Tanimoto, M. Tsuda, K. Ohama, M. Yoshizumi, and Y. Higashi
Tooth Loss Is Associated With an Increased Risk of Hypertension in Postmenopausal Women
Hypertension,
June 1, 2004;
43(6):
1297 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|